SMO-CLINICA's advanced capabilities enable pharmaceutical industry and biotechs clients to accelerate clinical trials and decrease the time, uncertainty and cost of drug development.
SMO-CLINICA can handle any study involving Outpatients focusing on Phase II, III and IV clinical trials.
Its clients include many of the world's top pharmaceutical and biotechnology companies.
SMO-CLINICA can handle any study involving Outpatients focusing mainly on the following Therapeutic Areas:
- Type 2 Diabetes
- Outcome studies
- Atrial Fibrillation
- Rheumatoid arthritis
- Women’s Health
- GI, …